Abstract
A reassortant influenza virus, A/duck/Hokkaido/Vac-1/2004 (H5N1) (Dk/Vac-1/04), was generated between non-pathogenic avian influenza viruses isolated from migratory ducks in Asia. Dk/Vac-1/04 (H5N1) virus particles propagated in embryonated chicken eggs were inactivated with formalin and adjuvanted with mineral oil to form a water-in-oil emulsion. The resulting vaccine was injected intramuscularly into chickens. The chickens were challenged with either of the highly pathogenic avian influenza virus strains A/chicken/Yamaguchi/7/2004 (H5N1) or A/swan/Mongolia/3/2005 (H5N1) at 21 days post-vaccination (p. v.), when the geometric mean serum HI titers of the birds was 64 with the challenge virus strains. The vaccinated chickens were protected from manifestation of disease signs upon challenge with either of the highly pathogenic avian influenza viruses. However, challenge virus was recovered at low titers from the birds at 2 and 4 days post-challenge (p.c.). All 3 chickens challenged at 6 days p.v. died, whereas 3 chickens challenged at 8 days p.v. survived. These results indicate that the present vaccine confers clinical protection and reduction of virus shedding against highly pathogenic avian influenza virus challenge and should be useful as an optional tool in emergency cases.
Similar content being viewed by others
References
Alexander DJ (2000) A review of avian influenza in different bird species. Vet Microbiol 74:3–13
Alexander DJ, Parsons G, Manvell RJ (1986) Experimental assessment of the pathogenicity of eight avian influenza A viruses of H5 subtypes for chickens, turkeys, ducks, and quail. Avian Pathol 15:647–662
Bublot M, Le Gros FX, Nieddu D, Pritchard N, Mickle TR, Swayne DE (2007) Efficacy of two H5N9-inactivated vaccines against challenge with a recent H5N1 highly pathogenic avian influenza isolate from a chicken in Thailand. Avian Dis 51:332–337
Bublot M, Pritchard N, Cruz JS, Mickle TR, Selleck P, Swayne DE (2007) Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge. Avian Dis 51:498–500
Chen H, Deng G, Li Z, Tian G, Li Y, Jiao P, Zhang L, Liu Z, Webster RG, Yu K (2004) The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci USA 101:10452–10457
Chen H, Smith GJ, Zhang SY, Qin K, Wang J, Li KS, Webster RG, Peiris JS, Guan Y (2005) Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 436:191–192
Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG (1998) Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472–477
EFSA (2007) Opinion of the scientific panel on animal health and welfare (AHAW) related with the vaccination against avian influenza of H5 and H7 subtypes in domestic poultry and captive birds. EFSA J 489
Ellis TM, Leung CY, Chow MK, Bissett LA, Wong W, Guan Y, Malik Peiris JS (2004) Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathol 33:405–412
Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus AD (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79:2814–2822
Gao W, Soloff AC, Lu X, Montecalvo A, Nguyen DC, Matsuoka Y, Robbins PD, Swayne DE, Donis RO, Katz JM, Barratt-Boyes SM, Gambotto A (2006) Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 80:1959–1964
Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146:2275–2289
Horimoto T, Nakayama K, Smeekens SP, Kawaoka Y (1994) Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J Virol 68:6074–6078
Isoda N, Sakoda Y, Kishida N, Bai GR, Matsuda K, Umemura T, Kida H (2006) Pathogenicity of a highly pathogenic avian influenza virus, A/chicken/Yamaguchi/7/04 (H5N1) in different species of birds and mammals. Arch Virol 151:1267–1279
Ito T, Okazaki K, Kawaoka Y, Takada A, Webster RG, Kida H (1995) Perpetuation of influenza A viruses in Alaskan waterfowl reservoirs. Arch Virol 140:1163–1172
Ito T, Goto H, Yamamoto E, Tanaka H, Takeuchi M, Kuwayama M, Kawaoka Y, Otsuki K (2001) Generation of a highly pathogenic avian influenza A virus from an avirulent field isolate by passaging in chickens. J Virol 75:4439–4443
Kishida N, Sakoda Y, Eto M, Sunaga Y, Kida H (2004) Co-infection of Staphylococcus aureus or Haemophilus paragallinarum exacerbates H9N2 influenza A virus infection in chickens. Arch Virol 149:2095–2104
Kishida N, Sakoda Y, Isoda N, Matsuda K, Eto M, Sunaga Y, Umemura T, Kida H (2005) Pathogenicity of H5 influenza viruses for ducks. Arch Virol 150:1383–1392
Klenk HD, Garten W (1994) Host cell proteases controlling virus pathogenicity. Trends Microbiol 2:39–43
Kumar M, Chu HJ, Rodenberg J, Krauss S, Webster RG (2007) Association of serologic and protective responses of avian influenza vaccines in chickens. Avian Dis 51:481–483
Lee MS, Deng MC, Lin YJ, Chang CY, Shieh HK, Shiau JZ, Huang CC (2007) Characterization of an H5N1 avian influenza virus from Taiwan. Vet Microbiol 124:193–201
Lierz M, Hafez HM, Klopfleisch R, Luschow D, Prusas C, Teifke JP, Rudolf M, Grund C, Kalthoff D, Mettenleiter T, Beer M, Hardert T (2007) Protection and virus shedding of falcons vaccinated against highly pathogenic avian influenza A virus (H5N1). Emerg Infect Dis 13:1667–1674
Liu J, Xiao H, Lei F, Zhu Q, Qin K, Zhang XW, Zhang XL, Zhao D, Wang G, Feng Y, Ma J, Liu W, Wang J, Gao GF (2005) Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 309:1206
Liu M, Wood JM, Ellis T, Krauss S, Seiler P, Johnson C, Hoffmann E, Humberd J, Hulse D, Zhang Y, Webster RG, Perez DR (2003) Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 314:580–590
Makarova NV, Ozaki H, Kida H, Webster RG, Perez DR (2003) Replication and transmission of influenza viruses in Japanese quail. Virology 310:8–15
Mase M, Tsukamoto K, Imada T, Imai K, Tanimura N, Nakamura K, Yamamoto Y, Hitomi T, Kira T, Nakai T, Kiso M, Horimoto T, Kawaoka Y, Yamaguchi S (2005) Characterization of H5N1 influenza A viruses isolated during the 2003–2004 influenza outbreaks in Japan. Virology 332:167–176
OIE (2004) OIE Manual of diagnostic tests and vaccines for terrestrial animals, 5th edn, Paris
Perez DR, Lim W, Seiler JP, Yi G, Peiris M, Shortridge KF, Webster RG (2003) Role of quail in the interspecies transmission of H9 influenza A viruses: molecular changes on HA that correspond to adaptation from ducks to chickens. J Virol 77:3148–3156
Rashid Manzoor YS, Aaron Mweene, Yoshimi Tsuda, Hiroshi Kida (2008) Phylogenic Analysis of the M genes of influenza viruses isolated from free-flying water birds from their northern territory to Hokkaido, Japan. Virus Genes (in press)
Reed LJ, Muench H (1938) A simple method for estimating fifty percent endpoints. Am J Hyg 37:493–497
Soda K, Sakoda Y, Isoda N, Kajihara M, Haraguchi Y, Shibuya H, Yoshida H, Sasaki T, Sakamoto R, Saijo K, Hagiwara J, Kida H (2008) Development of vaccine strains of H5 and H7 influenza viruses. Jpn J Vet Res (in press)
Steel J, Burmakina SV, Thomas C, Spackman E, Garcia-Sastre A, Swayne DE, Palese P (2008) A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine 26:522–531
Stieneke-Grober A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C, Klenk HD, Garten W (1992) Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J 11:2407–2414
Swayne DE, Lee CW, Spackman E (2006) Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathol 35:141–146
Tumpey TM, Kapczynski DR, Swayne DE (2004) Comparative susceptibility of chickens and turkeys to avian influenza A H7N2 virus infection and protective efficacy of a commercial avian influenza H7N2 virus vaccine. Avian Dis 48:167–176
Webster RG, Webby RJ, Hoffmann E, Rodenberg J, Kumar M, Seiler P, Krauss S, Songserm T (2006) The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology 351(2):303–311
WHO (2002) WHO manual on animal influenza diagnosis and surveillance, Geneva
WHO (2008) Cumulative number of confirmed human cases of avian influenza A/(H5N1)
Xu X, Subbarao, Cox NJ, Guo Y (1999) Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261: 15–19
Acknowledgments
We extend special thanks to the National Institute of Animal Health for providing the A/chicken/Yamaguchi/7/04 (H5N1) influenza virus strain. The present work is supported in part by the Program of Founding Research Centers for Emerging and Reemerging Infectious Disease from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Japan Racing and Livestock Promotion Foundation. N. I. is the fellow of Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Isoda, N., Sakoda, Y., Kishida, N. et al. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Arch Virol 153, 1685–1692 (2008). https://doi.org/10.1007/s00705-008-0171-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-008-0171-1